Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,731 | 326 | 99.1% |
| Education | $51.25 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $750.19 | 51 | $0 (2023) |
| GlaxoSmithKline, LLC. | $608.55 | 25 | $0 (2024) |
| AbbVie Inc. | $512.64 | 40 | $0 (2023) |
| Lilly USA, LLC | $446.72 | 24 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $430.44 | 25 | $0 (2023) |
| Amgen Inc. | $357.38 | 26 | $0 (2023) |
| Merck Sharp & Dohme LLC | $319.51 | 16 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $293.63 | 17 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $211.24 | 12 | $0 (2023) |
| PFIZER INC. | $200.61 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39.54 | 2 | GlaxoSmithKline, LLC. ($39.54) |
| 2023 | $2,863 | 145 | GlaxoSmithKline, LLC. ($403.70) |
| 2022 | $2,429 | 158 | Novo Nordisk Inc ($382.54) |
| 2021 | $450.52 | 27 | Novo Nordisk Inc ($40.86) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Gastroenterology | ||||||
| 08/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Gastroenterology | ||||||
| 08/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Obesity | ||||||
| 08/10/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Inflammation | ||||||
| 08/09/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: RESPIRATORY | ||||||
| 08/04/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: RESPIRATORY | ||||||
| 07/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Respiratory | ||||||
| 07/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Diabetes | ||||||
| 07/24/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Oncology | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 07/18/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 07/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 07/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: Diabetes | ||||||
| 07/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Inflammation | ||||||
| 07/13/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: GI | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 168 | 211 | $31,750 | $12,054 |
| 2022 | 7 | 191 | 232 | $33,458 | $15,151 |
| 2021 | 1 | 15 | 21 | $5,250 | $2,354 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 79 | $19,750 | $7,138 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 64 | $10,560 | $4,164 | 39.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 52 | $1,040 | $436.80 | 42.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $400.00 | $315.04 | 78.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 80 | $19,777 | $8,591 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 53 | $8,745 | $3,824 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $2,775 | $2,095 | 75.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 17 | 17 | $425.00 | $338.62 | 79.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $565.61 | $135.03 | 23.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 38 | 41 | $820.00 | $120.78 | 14.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 13 | 14 | $350.00 | $46.27 | 13.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 21 | $5,250 | $2,354 | 44.8% |
About Dr. Bharvi Balar, MD
Dr. Bharvi Balar, MD is a Family Medicine healthcare provider based in Shelton, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2017. The National Provider Identifier (NPI) number assigned to this provider is 1487187498.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bharvi Balar, MD has received a total of $5,782 in payments from pharmaceutical and medical device companies, with $39.54 received in 2024. These payments were reported across 332 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,731).
As a Medicare-enrolled provider, Balar has provided services to 374 Medicare beneficiaries, totaling 464 services with total Medicare billing of $29,559. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelton, CT
- Active Since 04/06/2017
- Last Updated 04/04/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487187498
Products in Payments
- TRELEGY ELLIPTA (Drug) $463.39
- JARDIANCE (Drug) $405.62
- FARXIGA (Drug) $347.73
- Rybelsus (Drug) $295.00
- XIFAXAN (Drug) $293.63
- UBRELVY (Drug) $214.38
- Ozempic (Drug) $210.81
- ELIQUIS (Drug) $210.68
- EVENITY (Biological) $182.41
- BELSOMRA (Drug) $165.76
- Linzess (Drug) $159.87
- ENTRESTO (Drug) $157.54
- XYWAV (Drug) $150.00
- QULIPTA (Drug) $148.59
- Cologuard Collection Kit (Device) $137.75
- Kerendia (Drug) $132.47
- Otezla (Drug) $123.72
- SYNTHROID (Drug) $93.19
- EMGALITY (Drug) $90.53
- Edarbi (Drug) $87.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelton
Dr. Samuel Streit, Do, DO
Family Medicine — Payments: $13,696
Dr. Elliot Mathias, M.d, M.D
Family Medicine — Payments: $7,058
Leon Rapko, D.o, D.O
Family Medicine — Payments: $2,360
Dr. Kenneth Ward, M.d, M.D
Family Medicine — Payments: $2,034
Dr. Parnian Kiamanesh, M.d, M.D
Family Medicine — Payments: $1,983
Andrea Buser, Pa-C, PA-C
Family Medicine — Payments: $1,760